As such HYAL-1 might play a role in tumor proliferation and cell cycle progression in ER-negative clear cell and mucinous EOC much in the same way as has been shown for ER-negative breast cancer [24], [79] and for bladder and prostate cancer cell lines [26], [27]. This evidence concerns the gene HYAL1 and prostate carcinoma.